The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management

The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management

Over the past decades, accumulating evidence has demonstrated a pivotal role of cholecystokinin type 2 receptor (CCK2R) in pain modulation. The established role of CCK2R activation in directly facilitating nociception has led to the development of several CCK2R antagonists, which have been shown to...

Full description

Bibliographic Details
Main Authors: Amandine Bernard, Aurore Danigo, Sylvie Bourthoumieu, Mohamad Mroué, Alexis Desmoulière, Franck Sturtz, Amandine Rovini, Claire Demiot
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceuticals
Subjects:
cholecystokinin type 2 receptor
pain management
antagonist
rodent model
clinical trial
Online Access:https://www.mdpi.com/1424-8247/14/11/1185

Internet

https://www.mdpi.com/1424-8247/14/11/1185

Similar Items